Gilead Sciences reported $11.24B in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acorda Therapeutics ACOR:US USD 37.95M 4.07M
Agios Pharmaceuticals AGIO:US USD 62.63M 9.03M
Alnylam Pharmaceuticals ALNY:US USD 767.92M 4.88M
Amgen AMGN:US USD 15.69B 1.36B
Biogen BIIB:US USD 3.27B 653.6M
Biomarin Pharmaceutical BMRN:US USD 588.88M 67.86M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Coherus Biosciences CHRS:US USD 138.69M 32.62M
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Glaxosmithkline GSK:US GBP 22.81B 1.86B
Intercept Pharmaceuticals ICPT:US USD 230.08M 8.49M
Moderna Inc MRNA:US USD 4.92B 1.88B
Neurocrine Biosciences NBIX:US USD 537.7M 52.6M
Novartis NOVN:VX USD 28.66B 496M
Ptc Therapeutics PTCT:US USD 406.24M 13.84M
Puma Biotechnology PBYI:US USD 77.48M 17.5M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Sangamo Biosciences SGMO:US USD 111.71M 10.65M
Sarepta Therapeutics SRPT:US USD 619.6M 16.69M
Teva Pharmaceutical Industries TEVA:US USD 11.47B 65M
United Therapeutics UTHR:US USD 343.2M 27.3M
Vertex Pharmaceuticals VRTX:US USD 2.43B 178.7M
YTE INCY:US USD 1.16B 150.48M